The Walter Reed Army Institute of Research has awarded LabVantage Solutions, Inc. a contract to supply its LabVantage Pharma laboratory information management system (LIMS) to support Covid-19 and other vaccine production programs at the institute’s pilot bioproduction facility. The web-based […]
Read MoreBiosimilar medicine availability and use are growing and on track to reduce drug costs by $100 billion over the next five years, according to a new report from the IQVIA Institute for Human Data Science. The development and approvals of […]
Read MoreAbzena, a contract provider of integrated services for biologics and bioconjugates, has invested $60 million into a new facility for late phase and commercial current good manufacturing practice (cGMP) production. The new 50,000 square foot ‘Lusk’ facility at the company’s site […]
Read MoreOmnicell, Inc. is rebranding its Population Health Solutions division into EnlivenHealth, a unit dedicated to enabling retail pharmacies and health plans to improve patient outcomes while reducing costs through software-as-a-service technology. The newly named division serves nearly 30,000 retail pharmacies […]
Read MoreSandoz Inc.’s first two injectable medicines featuring Radio Frequency Identification (RFID) tags will become available to U.S. hospitals beginning this month through a collaborative effort with automated medication management company Kit Check, Inc. The medicines include Anectine 200 mg/10mL and […]
Read MoreCryoport, Inc. has completed the acquisitions of MVE Biological Solutions, a global supplier of manufactured vacuum insulated products and cryogenic freezer systems, and CryoPDP, a provider of temperature-controlled logistics for the clinical research, pharmaceutical and cell and gene therapy markets. […]
Read MoreAtelerix, a biotech startup spun out of Newcastle University in 2017, is targeting a key problem of cellular and tissue therapies: the need to cryopreserve (often, at temperatures of -170°C, with liquid nitrogen) human (and mammalian) cells. In early September, […]
Read MoreFinancial analysts at SVB Leerink, a bank, are latching onto preliminary data from vaccine developers to make some estimates of commercial viability, according to reports published in Fierce Pharma. While the information gives some insight into what could happen as […]
Read More
On the heels of what would normally be considered a major acquisition by a relatively small company—Cryoport’s purchase of Paris-based CryoPDP—the company is now leaping ahead with a new acquisition: the life sciences business, MVE Biological Solutions, of Chart Industries. […]
Read More
EtectRx, one of a handful of companies pursuing what has variously been called “digital medicine,” “digital pills” and “ingestible sensors,” has appointed Valerie Sullivan as president and CEO, an executive experienced in patient support functions, and is going forward with […]
Read More
